Deep Innovation:
The Well-Oiled and the Cantankerous
by Tim Smith, PhD, 4 August 2004
<back |
| next>
What factor drives innovation into large companies
versus entrepreneurial firms? Should firms fund deep innovation
within or should innovation be driven through acquisitions? Should
entrepreneurs expect swift competition from goliaths or a few years
of solitude while they develop their market?
To a casual business observer, it may appear that innovation and
new product development occur everywhere continually, but this is
misleading. Most research and development investments deliver incremental
product improvements that enable companies to better serve their
current market. Deep innovations, the kind that produce entirely
new customer solutions and industries, are in fact quite rare. It
is this deep innovation that produces entirely new solutions to
customer challenges and subsequently creates new markets and revenue
growth.
Whether deep innovation is delivered
through entrepreneurship or corporate research and development
projects is not just an academic question. The understanding of
deep innovation and where it will occur influences business, investment,
and venture capital strategies. The difference between inside innovation
and outside innovation appears through the choices of executives
in established businesses when they trade-off spending $10 M in
acquisitions versus $10 M on internal R&D. Likewise, the difference
between corporate and entrepreneurial innovation drives employment
patterns and investment choices.
Exit plans for entrepreneurial firms often include
the possibility of being acquired by a larger firm. Large corporations
often establish Mergers and Acquisitions departments to scour the
landscape for promising new opportunities while maintaining a large
R&D division. Likewise, investors and venture capitalist are
continually hunting for the next big thing while, at the same time,
demanding growth from more established corporations. Should deep
innovation be nurtured within larger firms or be harvested from
entrepreneurs?
This article seeks to develop an understanding of
one factor that drives deep innovation into large corporations in
some industries while entrepreneurial firms lead in others. To develop
this understanding, we first examine held beliefs about deep innovation
from authors and corporations, then posit that a major factor that
drives deep innovation into large corporations rather than entrepreneurs
lies in the barriers to customers.
Corporations vs. Entrepreneurial
Firms
Large corporations are capable of deep innovation.
- Lou Lehr, a past CEO of 3M, increased R&D
investments and productivity to the point that in 1985, 25% of
their revenue was derived from new products introduced within
the previous 5 years. 3M’s business strategy was supported
by numerous internal rewards and opportunities for employees to
explore new ideas and develop potential products.(1)
- Pharmaceutical companies like Merk are known for
their ability to develop new formularies within their research
and development labs. The science of managing R&D at pharmaceutical
companies has progressed to the point that real options analysis
is a required skill within their finance departments.(2)
- Much of the innovations in silicon that enable
Moore’s Law to be achieved year after year are produced
by major corporations like TI, Intel, IBM, and others.
- If we examine the development of the CD, we find
the corporate giant Philips to be the champion in marketing this
technology despite the numerous competitors and researchers that
participated in its development.
From these examples, it is clear that a large number
of corporations in a variety of industries are able to produce deep
innovations. Yet, their hold on deep innovation is not exclusive.
Entrepreneurial firms continually enter industries with ideas that
are outside of the mainstream and yet successfully penetrate established
markets.
For instance, within the software industry, small
firms have delivered far more deep innovation than larger ones.
As The Economist noted, “Microsoft has one of the largest
research budgets in the world… . But it also has one of the
worst records when it comes to the efficiency of its research dollars
– ie, its actual records in innovation. Its success has overwhelmingly
been due to developing copy-cat technologies and paying top dollar
to buy promising small firms.”(3) And Microsoft
is not alone. Sungard grew to become one of the larger companies
in financial management software through its acquisition strategy
not its research and development. Likewise, SPL’s recent decision
to acquire rather than develop new software for the utilities vertical
rested in the ability of others to develop software outside of its
core knowledge domain.
The ability of others to develop new ideas has led
many industry analysts to suggest that funding deep innovation within
large corporations may be a misuse of funds. For instance, Hamel
& Getz stated in a recent HBR article: “Regardless of
how creative your employees may be, there’s more innovation
potential outside of your company than within it.” (4)
Even Geoffrey Moore relegates deep product innovation to the early
stages of a market and suggests that organizations focus on other
forms of innovation when serving maturing, mature, and declining
markets. (5)
These opposing cases and viewpoints drive the question:
Should innovation be pursued within large corporations or should
it be left to the entrepreneurial firms?
Barriers to Customers
If we focus our attention on the differences between the
industries wherein deep innovation is delivered by large corporations
versus those industries wherein deep innovation is delivered by
entrepreneurial firms, we can find that a key factor that drives
the source of deep innovation is customer access. Access to customers,
both for initial sales and marketing and for translating idea generation
into customer applications, is a key factor.
If we return to the case of pharmaceutical innovation,
we quickly uncover a customer access barrier in the form of the
FDA approval process. We can find a few entrepreneurs searching
for new formularies but their business development plan will call
for the licensing of their formulary to an established pharmaceutical
firm if not the outright sale of their company. In the past, entrepreneurial
companies in pharmaceuticals rarely intended to develop their formularies,
enter the market, and rival the established giants. Entrepreneurs
in pharmaceuticals avoid outright market development largely due
to the challenges of receiving FDA approval for their formularies.
The FDA approval process took an average of 7 years to complete
with numerous stages of trial. Few venture capitalists are willing
to fund an unproven company with such high exit barriers.
Likewise, the funding of deep innovations in hardware
requires the ability to reach customers. In the Philips CD example,
we find that the barriers to customer access arrived in the form
of industry coordination challenges. The sales of CD’s and
CD players needed the participation of music labels, CD manufacturers,
and competing CD player producers. Philips addressed this coordination
through a number of negotiations with each industry cohort. A smaller
entrepreneurial firm would not have had the strength and bargaining
latitude to undertake these complex negotiations.
In contrast, new ideas in software face relatively
fewer barriers to customer access when initiating sales and marketing.
Achieving the first few cornerstone customers is never easy for
entrepreneurial firms, but software entrepreneurs with new solutions
to customer challenges rarely face the challenges similar to the
FDA approval process or industry coordination. Once a few cornerstone
clients have been captured and retained, corporate concerns can
shift from development toward ramping up the sales and marketing
effort, either internally or through being acquired.
Deep Innovation guided by Customer Access
Customer access is not the only determinant
with regards to driving deep innovation. Other factors such as corporate
culture, innovative genius, competitive evolution, and funding clearly
influence the path of deep innovation. Yet customer access is clearly
a large determinant factor in choosing between nurturing innovation
within the well-oiled machines of corporations and harvesting innovation
from cantankerous entrepreneurs.
---
References
1. “3M: Profile of an Innovating Company”,
Harvard Business School, 1995.
2. Timothy A. Luehrman, “Investment Opportunities
as Real Options: Getting Started on the Numbers”, HBR, July-August
1998.
3. “An End to Growth”, The Economist,
July 24, 2004.
4. Gary Hamel & Gary Getz, “Funding Growth
in an Age of Austerity”, HBR, July-August 2004.
5. Geoffrey A. Moore, “Darwin and the Demon:
Innovating within Established Enterprises”, HBR, July-August
2004.
---
Author
Tim Smith, PhD is Editor of The Wiglaf Journal, Principal of Wiglaf
LLC, and Adjunct Professor at DePaul Graduate School of Business.
<back |
| next>
|